20th June 2026
Diagnosis and investigations
Table 6. Investigations for gestational hypertension
| Investigation |
Notes |
| Blood pressure measurement |
- Measure with the woman in a seated position
- Measure at least twice, 4 hours apart. The mean of the two readings is used to diagnose GH
|
| Urine protein |
- Collect a midstream urine sample for dipstick analysis
- If proteinuria is detected, a 24-hour urine collection should be performed to quantify the amount of protein secreted
|
| FBC |
- Anaemia can exacerbate hypertension
- Thrombocytopaenia is a potential complication of pre-eclampsia
|
| LFTs |
- Hepatic dysfunction is a potential complication of pre-eclampsia
- Elevated liver enzymes may prompt further investigations
|
| Renal function tests |
- Renal impairment is a potential complication of pre-eclampsia
|
| Coagulation studies |
- Coagulopathy is a potential complication of pre-eclampsia
|
| Foetal surveillance, e.g. assessing foetal movement or biophysical profile testing |
- Concerns about foetal well-being may prompt further investigations, such as umbilical artery doppler or foetal ultrasound
|
| Other |
- ECG for cardiac abnormalities
- CXR for pulmonary oedema
- Cranial imaging for cerebral haemorrhage or infarction
- Measurement of placental growth factor (PIGF): may reduce the delay in diagnosing pre-eclampsia
|
Severity classification of gestational hypertension:
- Hypertension: systolic BP ≥ 140/90 mmHg or diastolic BP ≥ 90 mmHg, or both
- Severe hypertension: BP persistently ≥ 160/100 mmHg for a minimum of 4 hours